154 related articles for article (PubMed ID: 34555379)
1. KIF12 Variants and Disturbed Hepatocyte Polarity in Children with a Phenotypic Spectrum of Cholestatic Liver Disease.
Stalke A; Sgodda M; Cantz T; Skawran B; Lainka E; Hartleben B; Baumann U; Pfister ED
J Pediatr; 2022 Jan; 240():284-291.e9. PubMed ID: 34555379
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel loci for pediatric cholestatic liver disease defined by KIF12, PPM1F, USP53, LSR, and WDR83OS pathogenic variants.
Maddirevula S; Alhebbi H; Alqahtani A; Algoufi T; Alsaif HS; Ibrahim N; Abdulwahab F; Barr M; Alzaidan H; Almehaideb A; AlSasi O; Alhashem A; Hussaini HA; Wali S; Alkuraya FS
Genet Med; 2019 May; 21(5):1164-1172. PubMed ID: 30250217
[TBL] [Abstract][Full Text] [Related]
3. Clinical exome sequencing reveals a novel pathogenic variant in KIF12 underlying cholestasis with highly variable phenotypes.
Waheed N; Waris R; Naseer M; Razzaq A; Suleman S; Ullah A
Clin Genet; 2024 Jan; 105(1):106-108. PubMed ID: 37866826
[TBL] [Abstract][Full Text] [Related]
4. Youngest Living Donor Liver Transplant for End-Stage Liver Disease in a 6-Month-Old With a Novel Aggressive Mutation in KIF12 Gene.
Gautam V; Panda K; Kumar V; Agarwal S; Gupta S
Pediatr Transplant; 2024 Aug; 28(5):e14804. PubMed ID: 38853137
[TBL] [Abstract][Full Text] [Related]
5. Cholestatic Liver Disease in a Child with KIF12 Mutation.
Samanta A; Sarma MS; Srivastava A; Poddar U
Indian J Pediatr; 2023 Nov; ():. PubMed ID: 37919484
[TBL] [Abstract][Full Text] [Related]
6. Genetic profiling of children with advanced cholestatic liver disease.
Shagrani M; Burkholder J; Broering D; Abouelhoda M; Faquih T; El-Kalioby M; Subhani SN; Goljan E; Albar R; Monies D; Mazhar N; AlAbdulaziz BS; Abdelrahman KA; Altassan N; Alkuraya FS
Clin Genet; 2017 Jul; 92(1):52-61. PubMed ID: 28039895
[TBL] [Abstract][Full Text] [Related]
7. Recessive Mutations in
Ünlüsoy Aksu A; Das SK; Nelson-Williams C; Jain D; Özbay Hoşnut F; Evirgen Şahin G; Lifton RP; Vilarinho S
Hepatol Commun; 2019 Apr; 3(4):471-477. PubMed ID: 30976738
[TBL] [Abstract][Full Text] [Related]
8. Sequencing of FIC1, BSEP and MDR3 in a large cohort of patients with cholestasis revealed a high number of different genetic variants.
Dröge C; Bonus M; Baumann U; Klindt C; Lainka E; Kathemann S; Brinkert F; Grabhorn E; Pfister ED; Wenning D; Fichtner A; Gotthardt DN; Weiss KH; McKiernan P; Puri RD; Verma IC; Kluge S; Gohlke H; Schmitt L; Kubitz R; Häussinger D; Keitel V
J Hepatol; 2017 Dec; 67(6):1253-1264. PubMed ID: 28733223
[TBL] [Abstract][Full Text] [Related]
9. Prominin-1-expressing hepatic progenitor cells induce fibrogenesis in murine cholestatic liver injury.
Fenlon M; Short C; Xu J; Malkoff N; Mahdi E; Hough M; Glazier A; Lee C; Asahina K; Wang KS
Physiol Rep; 2020 Jul; 8(14):e14508. PubMed ID: 32686913
[TBL] [Abstract][Full Text] [Related]
10. Expression Analysis of ATP-Binding Cassette Transporters ABCB11 and ABCB4 in Primary Sclerosing Cholangitis and Variety of Pediatric and Adult Cholestatic and Noncholestatic Liver Diseases.
Thoeni C; Waldherr R; Scheuerer J; Schmitteckert S; Roeth R; Niesler B; Cutz E; Flechtenmacher C; Goeppert B; Schirmacher P; Lasitschka F
Can J Gastroenterol Hepatol; 2019; 2019():1085717. PubMed ID: 31886153
[TBL] [Abstract][Full Text] [Related]
11. Structural and functional hepatocyte polarity and liver disease.
Gissen P; Arias IM
J Hepatol; 2015 Oct; 63(4):1023-37. PubMed ID: 26116792
[TBL] [Abstract][Full Text] [Related]
12. Liver pathology in severe multidrug resistant 3 protein deficiency: a series of 10 pediatric cases.
Vij M; Safwan M; Shanmugam NP; Rela M
Ann Diagn Pathol; 2015 Oct; 19(5):277-82. PubMed ID: 26117383
[TBL] [Abstract][Full Text] [Related]
13. Does the mutation of the SERPINA1 gene contribute to liver damage and cholestasis in patients with diagnosed cystic fibrosis? preliminary study.
Więcek S; Woś H; Kordys-Darmolińska B; Sankiewicz-Szkółka M; Grzybowska-Chlebowczyk U
Dev Period Med; 2015; 19(1):92-7. PubMed ID: 26003074
[TBL] [Abstract][Full Text] [Related]
14. Retrospective analysis of children with α-1 antitrypsin deficiency.
Comba A; Demirbaş F; Çaltepe G; Eren E; Kalayci AG
Eur J Gastroenterol Hepatol; 2018 Jul; 30(7):774-778. PubMed ID: 29505478
[TBL] [Abstract][Full Text] [Related]
15. Vps33b is crucial for structural and functional hepatocyte polarity.
Hanley J; Dhar DK; Mazzacuva F; Fiadeiro R; Burden JJ; Lyne AM; Smith H; Straatman-Iwanowska A; Banushi B; Virasami A; Mills K; Lemaigre FP; Knisely AS; Howe S; Sebire N; Waddington SN; Paulusma CC; Clayton P; Gissen P
J Hepatol; 2017 May; 66(5):1001-1011. PubMed ID: 28082148
[TBL] [Abstract][Full Text] [Related]
16. The Genetics of Inherited Cholestatic Disorders in Neonates and Infants: Evolving Challenges.
Jeyaraj R; Bounford KM; Ruth N; Lloyd C; MacDonald F; Hendriksz CJ; Baumann U; Gissen P; Kelly D
Genes (Basel); 2021 Nov; 12(11):. PubMed ID: 34828443
[TBL] [Abstract][Full Text] [Related]
17. Cholestatic liver disease.
Jüngst C; Lammert F
Dig Dis; 2013; 31(1):152-4. PubMed ID: 23797137
[TBL] [Abstract][Full Text] [Related]
18. ABCB4 mutations in adult patients with cholestatic liver disease: impact and phenotypic expression.
Degiorgio D; Crosignani A; Colombo C; Bordo D; Zuin M; Vassallo E; Syrén ML; Coviello DA; Battezzati PM
J Gastroenterol; 2016 Mar; 51(3):271-80. PubMed ID: 26324191
[TBL] [Abstract][Full Text] [Related]
19. Effect of drug transporter pharmacogenetics on cholestasis.
Dietrich CG; Geier A
Expert Opin Drug Metab Toxicol; 2014 Nov; 10(11):1533-51. PubMed ID: 25260651
[TBL] [Abstract][Full Text] [Related]
20. A Heterozygous ABCB4, RUNDC3B, and ABCB1 Deletion Associated With Severe Cholestatic Liver Disease in Adulthood.
Terziroli Beretta-Piccoli B; Thompson R; Foskett P; Cerny A; Merlo E; Vergani D; Rougemont AL; Moix I; Mieli-Vergani G; Morris M
Hepatology; 2019 Oct; 70(4):1484-1487. PubMed ID: 31127640
[No Abstract] [Full Text] [Related]
[Next] [New Search]
